Lexmark and Perceptive Software secured a number of notable customer wins, two of which are highlighted by Managed Print Services (MPS) agreements, a rapidly growing enterprise services segment for Lexmark. Lexmark continues to drive results for its MPS customers in the form of infrastructure optimization, workflow solutions and proactive management of printer fleets and supplies, ultimately reducing costs.
Perceptive Software’s customer wins included two deployments of its award-winning ImageNow Enterprise Content Management (ECM) solution to automate business processes and drive efficiency in the education and utility sectors.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/lexmark/48228/
After his win in Hungary, then a two-week F1-enforced summer shutdown, it's Lewis Hamilton's first day back at the 'office'. The MP4-24B may still essentially be the same car, but upgrades to the floor, rear and front wings mean the car is now competitive. With the consecutive races of Valencia and Spa next-up (although he won't now get the chance to race Michael Schumacher) Lewis can't wait to get back behind the wheel again...
Hey everybody! I know this song doesn't fit well to Hotch at all. I know but I don't care! I love this song, and I love this man. These two together make me fly so high above and make me swoon and make me smile!
IT'S FOR MY PLEASURE! ONLY MY PLEASURE! :DDDD
♥¸.•*´¨`*•.¸♥•.¸♥¸.•*´¨`*• .¸♥♥¸.•*´¨`*•.¸♥¸.•)´
(.•´
I'll look for You first in my next life
♥¸.•*´¨`*•.¸♥•.¸♥¸.•*´¨`*• .¸♥♥¸.•*´¨`*•.¸♥¸.•)´
(.•´
https://www.legalenglish.com/
Legal-Ease International is a unique company founded by Dena Falken. Legal-Ease International transforms its students education with its unique way of teaching. English and Legal English are two different languages. We travel the world and educated world famous clients on this difference. Visit our website at www.legalenglish.com Be part of Legal-Ease International today.
Beginning today, National Lobster Day, The Palm invites guests to satisfy cravings with a summer tradition – the return of a delectable four-pound lobster dinner for two served with two starters and one family-style side for just $99. Diners can take advantage of this fantastic lemon-squeezing, claw-cracking, butter-dripping special now through Aug. 15.
“With lobster season beginning in June, National Lobster Day is the perfect opportunity to kick-off what has become the most highly-anticipated tradition at The Palm,” said Bruce Bozzi Jr. Executive Vice President and fourth-generation Palm owner. “We’ve been in business for over 90 years and our guests are like family to us, so we love seeing so many familiar faces return each season to celebrate our lobster event of the year.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8122351-the-palm-restaurant-national-lobster-day/
By watching this video you can learn how to combine two integers and the video also shows you an example solved stepwise and for further help on related topics like Integer Rules - http://math.tutorvista.com/number-system/integers.html
This video shows you how to add two fractions and you can find an example in the video which is explained with step by step solution and you can also find help on Adding Fractions with Unlike Denominators - http://math.tutorvista.com/number-system/adding-fractions-with-unlike-denominators.html
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Spring means warmer weather, flowers starting to bloom and more time spent outdoors, so why not ring in spring by adding light and healthy new potato recipes to the dining table? Chef and Registered Dietitian Katie Cavuto Boyle stars in the US Potato Board’s “Seven Potato Types” educational video series and has created two new potato salad recipes perfect for the season. With seven unique potato types – Russets, reds, yellows, whites, purples, reds, fingerlings and petites – you can use a new type every night of the week!
To view Multimedia News Release, go to http://www.multivu.com/players/English/60495-potato-goodness
LeapFrog Enterprises, Inc. (NYSE:LF), the leader in educational entertainment, today announced Tag™ Human Body Discovery Pack, a unique two-sided interactive chart and game board that helps kids learn about the human body through discovery, exploration and play. Today elementary schools do not place enough emphasis on topics of science, healthy habits and nutrition, making it increasingly important to give kids the tools to make smart choices. LeapFrog’s highly experienced team of learning experts partnered with external medical professionals to create and refine the Tag Human Body Discovery Pack. This award-winning tool provides compelling learning experiences as kids learn human body facts, body systems, health and nutrition in a fun and engaging way.
The Tag Human Body Discovery Pack works with the #1 selling Tag™ Reading System and includes a jumbo two-sided chart and game board, interactive growth chart, three interactive sticker sheets with glow-in-the dark bone stickers, and more than 300 interactive responses and 40 learning activities.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54821-leapfrog-tag-human-body-discovery-pack-teach-kids
LeapFrog Enterprises, Inc. (NYSE:LF), the leader in educational entertainment, today announced two revolutionary new platforms: LeapPad2, the next generation of the #1 kid’s learning tablet LeapPad™, and LeapsterGS, the ultimate learning video game system.
Within a year of launch, LeapPad has received more than 20 accolades, including three prestigious awards from the Toy Industry Association (Educational Toy of the Year, Preschool Toy of the Year, and the ultimate recognition – Toy of the Year). LeapFrog introduces LeapPad2, the next generation of its magical tablet that delivers education filled with entertainment and fun creative exploration for kids.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54819-leapfrog-announces-leappad-2-and-leapster-gs
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
